These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21052757)

  • 1. Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies.
    Arnan M; Gudiol C; Calatayud L; Liñares J; Dominguez MÁ; Batlle M; Ribera JM; Carratalà J; Gudiol F
    Eur J Clin Microbiol Infect Dis; 2011 Mar; 30(3):355-60. PubMed ID: 21052757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.
    Gudiol C; Calatayud L; Garcia-Vidal C; Lora-Tamayo J; Cisnal M; Duarte R; Arnan M; Marin M; Carratalà J; Gudiol F
    J Antimicrob Chemother; 2010 Feb; 65(2):333-41. PubMed ID: 19959544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology.
    Rodríguez-Baño J; López-Cerero L; Navarro MD; Díaz de Alba P; Pascual A
    J Antimicrob Chemother; 2008 Nov; 62(5):1142-9. PubMed ID: 18641033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum β-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre.
    Nicolas-Chanoine MH; Gruson C; Bialek-Davenet S; Bertrand X; Thomas-Jean F; Bert F; Moyat M; Meiller E; Marcon E; Danchin N; Noussair L; Moreau R; Leflon-Guibout V
    J Antimicrob Chemother; 2013 Mar; 68(3):562-8. PubMed ID: 23143897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
    Komatsu Y; Kasahara K; Inoue T; Lee ST; Muratani T; Yano H; Kirita T; Mikasa K
    PLoS One; 2018; 13(8):e0202276. PubMed ID: 30157275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies.
    Vehreschild MJ; Hamprecht A; Peterson L; Schubert S; Häntschel M; Peter S; Schafhausen P; Rohde H; Lilienfeld-Toal MV; Bekeredjian-Ding I; Libam J; Hellmich M; Vehreschild JJ; Cornely OA; Seifert H
    J Antimicrob Chemother; 2014 Dec; 69(12):3387-92. PubMed ID: 25103492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caretaker knowledge, attitudes, and practices (KAP) and carriage of extended-spectrum beta-lactamase-producing E. coli (ESBL-EC) in children in Quito, Ecuador.
    Marusinec R; Kurowski KM; Amato HK; Saraiva-Garcia C; Loayza F; Salinas L; Trueba G; Graham JP
    Antimicrob Resist Infect Control; 2021 Jan; 10(1):2. PubMed ID: 33407927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal ESBL Escherichia coli carriage as a risk factor for bacteremia in patients with hematological malignancies.
    Cornejo-Juárez P; Suárez-Cuenca JA; Volkow-Fernández P; Silva-Sánchez J; Barrios-Camacho H; Nájera-León E; Velázquez-Acosta C; Vilar-Compte D
    Support Care Cancer; 2016 Jan; 24(1):253-259. PubMed ID: 26014616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.
    Ha YE; Kang CI; Cha MK; Park SY; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
    Int J Antimicrob Agents; 2013 Nov; 42(5):403-9. PubMed ID: 24071027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among humans in Java, Indonesia, in 2001-2002.
    Severin JA; Lestari ES; Kloezen W; Lemmens-den Toom N; Mertaniasih NM; Kuntaman K; Purwanta M; Duerink DO; Hadi U; van Belkum A; Verbrugh HA; Goessens WH;
    Trop Med Int Health; 2012 Apr; 17(4):455-61. PubMed ID: 22248076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infections caused by extended-spectrum β-lactamase-producing Enterobacterales after rectal colonization with ESBL-producing Escherichia coli or Klebsiella pneumoniae.
    Denkel LA; Maechler F; Schwab F; Kola A; Weber A; Gastmeier P; Pfäfflin F; Weber S; Werner G; Pfeifer Y; Pietsch M; Leistner R
    Clin Microbiol Infect; 2020 Aug; 26(8):1046-1051. PubMed ID: 31809805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal carriage rates of extended-spectrum β-lactamase-producing Escherichia coli among antibiotic naive healthy human volunteers.
    Mathai D; Kumar VA; Paul B; Sugumar M; John KR; Manoharan A; Kesavan LM
    Microb Drug Resist; 2015 Feb; 21(1):59-64. PubMed ID: 25127253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study.
    Denis B; Lafaurie M; Donay JL; Fontaine JP; Oksenhendler E; Raffoux E; Hennequin C; Allez M; Socie G; Maziers N; Porcher R; Molina JM
    Int J Infect Dis; 2015 Oct; 39():1-6. PubMed ID: 26189774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence and Comparative Genomics Analysis of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Carrying
    Feng C; Wen P; Xu H; Chi X; Li S; Yu X; Lin X; Wu S; Zheng B
    mSphere; 2019 Nov; 4(6):. PubMed ID: 31748247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.
    Matsumura Y; Nagao M; Iguchi M; Yagi T; Komori T; Fujita N; Yamamoto M; Matsushima A; Takakura S; Ichiyama S
    Clin Microbiol Infect; 2013 Feb; 19(2):161-8. PubMed ID: 22332968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission dynamics of extended-spectrum β-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting.
    Hilty M; Betsch BY; Bögli-Stuber K; Heiniger N; Stadler M; Küffer M; Kronenberg A; Rohrer C; Aebi S; Endimiani A; Droz S; Mühlemann K
    Clin Infect Dis; 2012 Oct; 55(7):967-75. PubMed ID: 22718774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.
    Trecarichi EM; Tumbarello M; Spanu T; Caira M; Fianchi L; Chiusolo P; Fadda G; Leone G; Cauda R; Pagano L
    J Infect; 2009 Apr; 58(4):299-307. PubMed ID: 19272650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of rectal carriage of extended-spectrum beta-lactamase-producing Escherichia coli among elderly people in community settings in China.
    Tian SF; Chen BY; Chu YZ; Wang S
    Can J Microbiol; 2008 Sep; 54(9):781-5. PubMed ID: 18772941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates].
    Görgeç S; Kuzucu Ç; Otlu B; Yetkin F; Ersoy Y
    Mikrobiyol Bul; 2015 Jan; 49(1):15-25. PubMed ID: 25706727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged colonisation with Escherichia coli O25:ST131 versus other extended-spectrum beta-lactamase-producing E. coli in a long-term care facility with high endemic level of rectal colonisation, the Netherlands, 2013 to 2014.
    Overdevest I; Haverkate M; Veenemans J; Hendriks Y; Verhulst C; Mulders A; Couprie W; Bootsma M; Johnson J; Kluytmans J
    Euro Surveill; 2016 Oct; 21(42):. PubMed ID: 27784530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.